Currently, there are limited supplies of the reagents used for HIV-1 Western Blot and HIV-2 EIA testing. In order to conserve the remaining reagent, a controlled process of batch testing was implemented. Therefore, you will likely see additional delays in receiving these supplemental test results.
Read about our plan to mitigate this on the Communications page by clicking this link: Communications
CTS received notification from Sanochemia Pharmazeutika AG of their intent to immediately discontinu...
On September 14, 2020, our Phoenix laboratory began performing a portion of our alternate donor anti...
Daylight Saving Time Begins March 10, 2019. As a friendly reminder, airlines often change their rout...
On February 18, 2019, the new CTS Laboratory Information System was successfully implemented in Tamp...
On July 6, 2018 the FDA released an industry guidance document for transitioning from individual to ...
On September 23, 2019, the new CTS Laboratory Information System successfully implemented in Da...